Skip to main content
Top
Published in: Acta Diabetologica 9/2018

01-09-2018 | Original Article

Aerobic training improves platelet function in type 2 diabetic patients: role of microRNA-130a and GPIIb

Authors: Atousa Akbarinia, Mehdi Kargarfard, Mahmood Naderi

Published in: Acta Diabetologica | Issue 9/2018

Login to get access

Abstract

Aims

MicroRNAs (miRs) that are mediators of gene expression have been implicated in type 2 diabetes mellitus (T2DM). Platelet hyper-reactivity is one of the most important disorders in T2DM patients. In this study, we explored the effects of aerobic training (AT) on platelet aggregation and Glycoprotein IIb (GPIIb) receptor and miR-130a expression.

Methods

In a quasi-experimental controlled trial, 24 sedentary, eligible female participants with T2DM were selected (age 61.92 ± 3.63) and divided into AT and control (CON) groups based on their peak oxygen consumption (VO2peak). AT protocol was performed three times per week in non-consecutive days on a treadmill with mean intensity (60–75% VO2peak) for 8 weeks, while the control group refrained from any type of exercise training. Two blood samples were taken before and after this period. Real-time PCR was used to determine the expression of platelet GPIIb and miR-130a. Moreover, platelet indices (PLT, MPV, PDW, and PCT), collagen-induced platelet aggregation and glycemic variables were measured.

Results

Analyses of data showed that anthropometric variables, VO2peak and glycemic control improved significantly (P < 0.01) after AT. Furthermore, MPV, PDW (P < 0.01), and platelet aggregation (P < 0.001) decreased significantly following AT compared with control group. Platelet GPIIb expression down-regulated significantly (P < 0.05) in AT group but up-regulation of miR-130a expression was not significant between two groups (P > 0.05).

Conclusions

Platelet hyper-reactivity in T2DM females might be decreased not only by glycemic control and amelioration of anthropometric and platelet indices, but also the down-regulation of GPIIb following AT. However, more research is needed to determine the effects of exercise training on platelet miR-130a.
Literature
1.
go back to reference Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311–321CrossRefPubMed Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311–321CrossRefPubMed
2.
go back to reference Kakouros N, Rade JJ, Kourliouros A, Resar JR (2011) Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol 2011:742719CrossRefPubMedPubMedCentral Kakouros N, Rade JJ, Kourliouros A, Resar JR (2011) Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol 2011:742719CrossRefPubMedPubMedCentral
4.
go back to reference Ferreiro JL, Angiolillo DJ (2010) Platelet abnormalities in diabetes mellitus. Diabetes Vasc Dis Res 7:251–259 (1479164110383994) CrossRef Ferreiro JL, Angiolillo DJ (2010) Platelet abnormalities in diabetes mellitus. Diabetes Vasc Dis Res 7:251–259 (1479164110383994) CrossRef
5.
6.
go back to reference Neki N (2004) Platelet glycoprotein IIb/IIIa receptor inhibitors–role in coronary artery disease. J Indian Acad Clin Med 5(3):259–265 Neki N (2004) Platelet glycoprotein IIb/IIIa receptor inhibitors–role in coronary artery disease. J Indian Acad Clin Med 5(3):259–265
7.
go back to reference Kalantzi KI, Tsoumani ME, Goudevenos IA, Tselepis AD (2012) Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives. Expert Rev Clin Pharmacol 5(3):319–336CrossRefPubMed Kalantzi KI, Tsoumani ME, Goudevenos IA, Tselepis AD (2012) Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives. Expert Rev Clin Pharmacol 5(3):319–336CrossRefPubMed
8.
go back to reference Wagner CL, Mascelli M, Neblock D, Weisman H, Coller B, Jordan R (1996) Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 88(3):907–914PubMed Wagner CL, Mascelli M, Neblock D, Weisman H, Coller B, Jordan R (1996) Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 88(3):907–914PubMed
9.
go back to reference Tschoepe D, Roesen P, Kaufmann L et al (1990) Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Investig 20(2Part 1):166–170CrossRef Tschoepe D, Roesen P, Kaufmann L et al (1990) Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Investig 20(2Part 1):166–170CrossRef
10.
go back to reference Razmara M, Hjemdahl P, Östenson CG, Li N (2008) Platelet hyperprocoagulant activity in Type 2 diabetes mellitus: attenuation by glycoprotein IIb/IIIa inhibition. J Thromb Haemost 6(12):2186–2192CrossRefPubMed Razmara M, Hjemdahl P, Östenson CG, Li N (2008) Platelet hyperprocoagulant activity in Type 2 diabetes mellitus: attenuation by glycoprotein IIb/IIIa inhibition. J Thromb Haemost 6(12):2186–2192CrossRefPubMed
11.
go back to reference Roffi M, Chew DP, Mukherjee D et al (2001) Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 104(23):2767–2771CrossRefPubMed Roffi M, Chew DP, Mukherjee D et al (2001) Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 104(23):2767–2771CrossRefPubMed
12.
go back to reference Lincoff AM (2003) Important triad in cardiovascular medicine diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade. Circulation 107(11):1556–1559CrossRefPubMed Lincoff AM (2003) Important triad in cardiovascular medicine diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade. Circulation 107(11):1556–1559CrossRefPubMed
13.
go back to reference Stakos DA, Gatsiou A, Stamatelopoulos K, Tselepis AD, Stellos K (2013) Platelet microRNAs: from platelet biology to possible disease biomarkers and therapeutic targets. Platelets 24(8):579–589CrossRefPubMed Stakos DA, Gatsiou A, Stamatelopoulos K, Tselepis AD, Stellos K (2013) Platelet microRNAs: from platelet biology to possible disease biomarkers and therapeutic targets. Platelets 24(8):579–589CrossRefPubMed
14.
go back to reference Edelstein LC, McKenzie S, Shaw C, Holinstat M, Kunapuli S, Bray P (2013) MicroRNAs in platelet production and activation. J Thromb Haemost 11(s1):340–350CrossRefPubMed Edelstein LC, McKenzie S, Shaw C, Holinstat M, Kunapuli S, Bray P (2013) MicroRNAs in platelet production and activation. J Thromb Haemost 11(s1):340–350CrossRefPubMed
15.
go back to reference Garzon R, Pichiorri F, Palumbo T et al (2006) MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 103(13):5078–5083CrossRefPubMed Garzon R, Pichiorri F, Palumbo T et al (2006) MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 103(13):5078–5083CrossRefPubMed
16.
17.
go back to reference Zampetaki A, Kiechl S, Drozdov I et al (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107(6):810–817CrossRefPubMed Zampetaki A, Kiechl S, Drozdov I et al (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107(6):810–817CrossRefPubMed
18.
go back to reference Duan X, Zhan Q, Song B et al (2014) Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke. J Diabetes Complic 28(5):705–710CrossRef Duan X, Zhan Q, Song B et al (2014) Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke. J Diabetes Complic 28(5):705–710CrossRef
19.
go back to reference Marwick TH, Hordern MD, Miller T et al (2009) Exercise training for type 2 diabetes mellitus impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119(25):3244–3262CrossRefPubMed Marwick TH, Hordern MD, Miller T et al (2009) Exercise training for type 2 diabetes mellitus impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119(25):3244–3262CrossRefPubMed
20.
go back to reference Way KL, Hackett DA, Baker MK, Johnson NA (2016) The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J 40(4):253–271CrossRefPubMedPubMedCentral Way KL, Hackett DA, Baker MK, Johnson NA (2016) The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J 40(4):253–271CrossRefPubMedPubMedCentral
21.
go back to reference Boulé N, Kenny G, Haddad E, Wells G, Sigal R (2003) Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 46(8):1071–1081CrossRefPubMed Boulé N, Kenny G, Haddad E, Wells G, Sigal R (2003) Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 46(8):1071–1081CrossRefPubMed
22.
go back to reference Wang J-S, Chow S-E (2004) Effects of exercise training and detraining on oxidized low-density lipoprotein-potentiated platelet function in men. Arch Phys Med Rehabilit 85(9):1531–1537CrossRef Wang J-S, Chow S-E (2004) Effects of exercise training and detraining on oxidized low-density lipoprotein-potentiated platelet function in men. Arch Phys Med Rehabilit 85(9):1531–1537CrossRef
23.
go back to reference Cardoso AM, Bagatini MD, Martins CC et al (2012) Exercise training prevents ecto-nucleotidases alterations in platelets of hypertensive rats. Mol Cell Biochem 371(1–2):147–156CrossRefPubMed Cardoso AM, Bagatini MD, Martins CC et al (2012) Exercise training prevents ecto-nucleotidases alterations in platelets of hypertensive rats. Mol Cell Biochem 371(1–2):147–156CrossRefPubMed
24.
go back to reference Di Massimo C, Scarpelli P, Penco M, Tozzi-Ciancarelli M (2004) Possible involvement of plasma antioxidant defences in training-associated decrease of platelet responsiveness in humans. Eur J Appl Physiol 91(4):406–412CrossRefPubMed Di Massimo C, Scarpelli P, Penco M, Tozzi-Ciancarelli M (2004) Possible involvement of plasma antioxidant defences in training-associated decrease of platelet responsiveness in humans. Eur J Appl Physiol 91(4):406–412CrossRefPubMed
25.
go back to reference De Meirelles L, Mendes-Ribeiro A, Mendes M et al (2009) Chronic exercise reduces platelet activation in hypertension: upregulation of the l-arginine-nitric oxide pathway. Scand J Med Sci Sports 19(1):67–74CrossRefPubMed De Meirelles L, Mendes-Ribeiro A, Mendes M et al (2009) Chronic exercise reduces platelet activation in hypertension: upregulation of the l-arginine-nitric oxide pathway. Scand J Med Sci Sports 19(1):67–74CrossRefPubMed
26.
go back to reference Ficicilar H, Zergeroglu A, Ersoz G, Erdogan A (2006) The effects of short-term training on platelet functions and total antioxidant capacity in rats. Physiol Res 55(2):151PubMed Ficicilar H, Zergeroglu A, Ersoz G, Erdogan A (2006) The effects of short-term training on platelet functions and total antioxidant capacity in rats. Physiol Res 55(2):151PubMed
27.
go back to reference Nielsen S, Åkerström T, Rinnov A et al (2014) The miRNA plasma signature in response to acute aerobic exercise and endurance training. PloS One 9(2):e87308CrossRefPubMedPubMedCentral Nielsen S, Åkerström T, Rinnov A et al (2014) The miRNA plasma signature in response to acute aerobic exercise and endurance training. PloS One 9(2):e87308CrossRefPubMedPubMedCentral
28.
go back to reference Baggish AL, Hale A, Weiner RB et al (2011) Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol 589(16):3983–3994CrossRefPubMedPubMedCentral Baggish AL, Hale A, Weiner RB et al (2011) Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol 589(16):3983–3994CrossRefPubMedPubMedCentral
29.
go back to reference Association GAotWM (2014) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent 81 (3):14 Association GAotWM (2014) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent 81 (3):14
30.
go back to reference Naderi M, Tehrani HA, Soleimani M, Shabani I, Hashemi SM (2015) A home-brew real-time PCR assay for reliable detection and quantification of mature miR-122. Appl Immunohistochem Mol Morphol 23(8):601–606CrossRefPubMed Naderi M, Tehrani HA, Soleimani M, Shabani I, Hashemi SM (2015) A home-brew real-time PCR assay for reliable detection and quantification of mature miR-122. Appl Immunohistochem Mol Morphol 23(8):601–606CrossRefPubMed
31.
go back to reference Jorge MLMP, de Oliveira VN, Resende NM et al (2011) The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism 60(9):1244–1252CrossRefPubMed Jorge MLMP, de Oliveira VN, Resende NM et al (2011) The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism 60(9):1244–1252CrossRefPubMed
32.
go back to reference Hawley J, Lessard S (2008) Exercise training-induced improvements in insulin action. Acta Physiol 192(1):127–135CrossRef Hawley J, Lessard S (2008) Exercise training-induced improvements in insulin action. Acta Physiol 192(1):127–135CrossRef
33.
go back to reference Randle P, Garland P, Hales C, Newsholme E (1963) The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281(7285):785–789CrossRef Randle P, Garland P, Hales C, Newsholme E (1963) The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281(7285):785–789CrossRef
34.
go back to reference Yenigün EC, Okyay GU, Pirpir A, Hondur A, Yıldırım İS (2014) Increased mean platelet volume in type 2 diabetes mellitus. Dicle Tıp Dergisi 41(1):17–22CrossRef Yenigün EC, Okyay GU, Pirpir A, Hondur A, Yıldırım İS (2014) Increased mean platelet volume in type 2 diabetes mellitus. Dicle Tıp Dergisi 41(1):17–22CrossRef
36.
go back to reference Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T (2009) The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complic 23(2):89–94CrossRef Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T (2009) The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complic 23(2):89–94CrossRef
37.
go back to reference Radom-Aizik S, Zaldivar FP, Haddad F, Cooper DM (2014) Impact of brief exercise on circulating monocyte gene and microRNA expression: implications for atherosclerotic vascular disease. Brain Behav Immun 39:121–129CrossRefPubMedPubMedCentral Radom-Aizik S, Zaldivar FP, Haddad F, Cooper DM (2014) Impact of brief exercise on circulating monocyte gene and microRNA expression: implications for atherosclerotic vascular disease. Brain Behav Immun 39:121–129CrossRefPubMedPubMedCentral
38.
go back to reference Radom-Aizik S, Zaldivar F Jr, Oliver S, Galassetti P, Cooper DM (2010) Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes. J Appl Physiol 109(1):252–261CrossRefPubMedPubMedCentral Radom-Aizik S, Zaldivar F Jr, Oliver S, Galassetti P, Cooper DM (2010) Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes. J Appl Physiol 109(1):252–261CrossRefPubMedPubMedCentral
39.
go back to reference Silva GJ, Bye A, el Azzouzi H, Wisløff U (2017) MicroRNAs as important regulators of exercise adaptation. Prog Cardiovasc Dis 60(1):130–151CrossRefPubMed Silva GJ, Bye A, el Azzouzi H, Wisløff U (2017) MicroRNAs as important regulators of exercise adaptation. Prog Cardiovasc Dis 60(1):130–151CrossRefPubMed
40.
go back to reference Russell AP, Lamon S, Boon H et al (2013) Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training. J Physiol 591(18):4637–4653CrossRefPubMedPubMedCentral Russell AP, Lamon S, Boon H et al (2013) Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training. J Physiol 591(18):4637–4653CrossRefPubMedPubMedCentral
Metadata
Title
Aerobic training improves platelet function in type 2 diabetic patients: role of microRNA-130a and GPIIb
Authors
Atousa Akbarinia
Mehdi Kargarfard
Mahmood Naderi
Publication date
01-09-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 9/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1167-2

Other articles of this Issue 9/2018

Acta Diabetologica 9/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.